{"title": "PDF", "author": "PDF", "url": "https://bb.uab.edu/medicine/icos/images/POCC_Report/Bi-weekly_POCC_Report/Vaccine.1.26.2022.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Age: Median (Range) 16y (0-39) N % Gender Female 62 44% Race / Ethnicity Non -Hispanic White 71 50% Hispanic or Latino 36 25% Black 24 17% Insurance Public/Uninsured 40 28% Private 97 68% Vaccination Location Oncology Office 32 22% *To report cases, find the POCC report, a copy this report and FAQs, visit: https://www.uab.edu/medicine/icos/icos -research/the -pocc -report Allergic Reaction History History of Allergic Reaction 58 41% To Previous Vaccines 1 2% To Pegylated Asparaginase 15 25% ToEtoposide 1 2% Other 45 76%Median Days Between Last Chemotherapy and Vaccine : 14 days (IQR: 1-59)Patients, Vaccines, and Reactogenicity Local/Systemic Reactions: Chills, Fatigue, Fever, Headache, Injection Site Pain, Myalgias , Nausea, Vomiting "}